Search results
Pfizer, Moderna Covid vaccine patents battle to continue after UK ruling
Business Standard India· 4 days agoPfizer and Moderna's legal battle over their rival Covid-19 vaccines looks set to continue after...
UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case | World News - The Indian...
Indian Express· 4 days agoPfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022,...
Lab to jab in 100 days: manufacturing flexibility for future rapid responses
Pharmaceutical Technology· 5 days agoThe Coalition for Epidemic Preparedness Innovations (CEPI) is on a mission to explore whether new...
Today’s Top News Headlines and Latest News at 8:30 pm on 2 July 2024
Indian Express· 4 days agoBeginning today's evening bulletin with the top news of the day: Prime Minister Narendra Modi addressed the 18th Lok Sabha for the first time today, amid Opposition protests. Modi, meanwhile ...
CureVac cuts jobs, licenses out vaccines to GSK
BioPharma Dive· 3 days agoThe mRNA specialist plans to eliminate 30% of its workforce as part of a restructuring that will prioritize “high-value” projects like its cancer...
GSK and CureVac restructure mRNA vaccine development deal
Pharmaceutical Technology· 3 days agoIn July 2023, Curevac asserted an intellectual property right claim for mRNA technology in addition...
Building capacity for new modalities: Inside Cytiva’s first end-to-end cGMP facility for mRNA...
Pharmaceutical Technology· 5 days agomRNA vaccines are a key focus for the biopharma industry. Despite this, there has been a lack of...